# Glucosamine Stiffness Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/glucosamine-stiffness-meta-analysis-evidence-review
Category: evidence-review
Summary: Glucosamine Stiffness Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-07-26
Reviewed by: Migaku Evidence Review
# Glucosamine Stiffness Meta-analysis: What the Evidence Says

## Quick Answer

Glucosamine Stiffness Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews | systematic review | 1 | 2026-05-21 | 10.3389/fmed.2026.1801273 |
| Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion | preclinical study | 4 | 2026-05-21 | 10.7759/cureus.109411 |

## What The Sources Report

- Non-steroidal anti-inflammatory drugs (NSAIDs), as first-line pharmacological agents, provide symptomatic improvement but are associated with gastrointestinal bleeding and cardiovascular risks upon prolonged administration. [Shi Chuankai (2026); evidence level 1]
- Systematic reviews and meta-analyses of observational studies indicate substantial heterogeneity in NSAID utilization among OA patients, with generally limited evidence quality. [Shi Chuankai (2026); evidence level 1]
- It causes chronic pain, reduced mobility, and disability, affecting 607 million individuals worldwide, with nearly 46.6 million new cases annually. [Muacevic Alexander (2026); evidence level 4]
- HLA-DRB1 HLA-DQB1 Genetic polymorphisms in sterol regulatory element-binding protein 2 (rs2228314), interleukin-6 (rs1800795), and resistin (RETN) in Indian and Pakistani cohorts and growth differentiation factor 5 (rs143383),, andin Thai populations are linked to OA risk. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For glucosamine stiffness meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Shi Chuankai (2026). Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews. DOI: 10.3389/fmed.2026.1801273. PMCID: PMC13233388. PMID: 42254374. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13233388/
- Muacevic Alexander (2026). Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion. DOI: 10.7759/cureus.109411. PMCID: PMC13283519. PMID: 42333321. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13283519/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.